COSMO Pharmaceuticals SA (0RGI) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.002x

Based on the latest financial reports, COSMO Pharmaceuticals SA (0RGI) has a cash flow conversion efficiency ratio of 0.002x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (£900.00K ≈ $1.21 Million USD) by net assets (£466.98 Million ≈ $627.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

COSMO Pharmaceuticals SA - Cash Flow Conversion Efficiency Trend (2004–2024)

This chart illustrates how COSMO Pharmaceuticals SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read COSMO Pharmaceuticals SA (0RGI) financial obligations for a breakdown of total debt and financial obligations.

COSMO Pharmaceuticals SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of COSMO Pharmaceuticals SA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Perrigo Company PLC NYSE:PRGO	0.012x
J & J Snack Foods Corp NASDAQ:JJSF	0.039x
Mayinglong Pharmaceutical Group Co Ltd SHG:600993	0.031x
Peloton Interactive Inc NASDAQ:PTON	-0.220x
Shanxi Huaxiang Group Co Ltd SHG:603112	-0.002x
Sinostone Guangdong Co Ltd SHE:001212	0.012x
Shenzhen Urban Transport Planning Center Co. Ltd. SHE:301091	N/A
IGNITIS GRUPE AB EO 2233 F:IGV0	N/A

Annual Cash Flow Conversion Efficiency for COSMO Pharmaceuticals SA (2004–2024)

The table below shows the annual cash flow conversion efficiency of COSMO Pharmaceuticals SA from 2004 to 2024. For the full company profile with market capitalisation and key ratios, see COSMO Pharmaceuticals SA (0RGI) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	£505.09 Million ≈ $678.29 Million	£162.41 Million ≈ $218.10 Million	0.322x	+507.52%
2023-12-31	£429.04 Million ≈ $576.16 Million	£22.71 Million ≈ $30.49 Million	0.053x	-25.38%
2022-12-31	£463.79 Million ≈ $622.83 Million	£32.89 Million ≈ $44.17 Million	0.071x	+188.34%
2021-12-31	£512.68 Million ≈ $688.48 Million	£12.61 Million ≈ $16.94 Million	0.025x	-24.20%
2020-12-31	£400.12 Million ≈ $537.33 Million	£12.98 Million ≈ $17.44 Million	0.032x	+167.80%
2019-12-31	£393.73 Million ≈ $528.75 Million	£-18.85 Million ≈ $-25.31 Million	-0.048x	-109.50%
2018-12-31	£444.85 Million ≈ $597.40 Million	£-10.16 Million ≈ $-13.65 Million	-0.023x	-7.32%
2017-12-31	£470.12 Million ≈ $631.32 Million	£-10.01 Million ≈ $-13.44 Million	-0.021x	-133.50%
2016-12-31	£415.56 Million ≈ $558.06 Million	£26.41 Million ≈ $35.47 Million	0.064x	+165.40%
2015-12-31	£403.65 Million ≈ $542.06 Million	£-39.23 Million ≈ $-52.68 Million	-0.097x	-122.27%
2014-12-31	£152.29 Million ≈ $204.51 Million	£66.45 Million ≈ $89.23 Million	0.436x	+1084.01%
2013-12-31	£220.16 Million ≈ $295.65 Million	£8.11 Million ≈ $10.90 Million	0.037x	-80.04%
2012-12-31	£124.60 Million ≈ $167.33 Million	£23.00 Million ≈ $30.89 Million	0.185x	+3.72%
2011-12-31	£63.43 Million ≈ $85.19 Million	£11.29 Million ≈ $15.16 Million	0.178x	+33.42%
2010-12-31	£58.37 Million ≈ $78.38 Million	£7.79 Million ≈ $10.46 Million	0.133x	+105.80%
2009-12-31	£59.80 Million ≈ $80.30 Million	£3.88 Million ≈ $5.21 Million	0.065x	+122.39%
2008-12-31	£43.24 Million ≈ $58.06 Million	£-12.52 Million ≈ $-16.81 Million	-0.290x	-303.62%
2007-12-31	£35.15 Million ≈ $47.20 Million	£-2.52 Million ≈ $-3.39 Million	-0.072x	-106.31%
2006-12-31	£5.34 Million ≈ $7.18 Million	£6.08 Million ≈ $8.16 Million	1.137x	-57.78%
2005-12-31	£631.00K ≈ $847.38K	£1.70 Million ≈ $2.28 Million	2.694x	+1008.37%
2004-12-31	£-880.00K ≈ $-1.18 Million	£261.00K ≈ $350.50K	-0.297x	--

About COSMO Pharmaceuticals SA

LSE:0RGI UK

Market Cap

$1.64 Billion

£1.22 Billion GBP

Market Cap Rank

#7004 Global

#17 in UK

Share Price

£81.43

Change (1 day)

-3.22%

52-Week Range

£47.95 - £125.25

All Time High

£173.85